Literature DB >> 22886978

Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells.

Li Wu1, Zhen Chen1, Jian Zhang2, Yiqiao Xing3.   

Abstract

This study investigated the effect of etoposide, an anticancer chemotherapy drug, on B7-H1 expression in retinoblastoma (Rb) cells and the role of miR-513a-5p in the process. Rb cells were divided into control and etoposide groups. In the etoposide group, cells were treated with etoposide at different concentrations (2.5, 5, 10, 20 and 40 μg/mL) for 24 h. Those given no treatment of etopside served as controls. Reverse transcription polymerase chain reaction (RT-PCR), fluorescence quantitative PCR and flow cytometry were performed to measure the mRNA and protein expression of B7-H1 in Rb cells. The mRNA expression of miR-513a-5p in Rb cells before and after etoposide treatment was also detected by fluorescence quantitative PCR. The miR-513a-5p mimics and the miR-513a-5p inhibitor were transfected into Rb cells separately, and fluorescence quantitative PCR and flow cytometry were used to detect the effect of the miR-513a-5p mimics or inhibitor on B7-H1 expression. TargetScan5.2 was employed to predict the miR-513a-5p binding sites in the 3'-untranslated region of B7-H1 mRNA. Luciferase reporter plasmids carrying this site were prepared and transfected into Rb cells and luciferase activity analyzed. The results showed that etoposide stimulated the mRNA and protein expression of B7-H1 in Rb cells, which reached a maximal level after treatment with 5 μg/mL etoposide (P<0.05). However, miR-513a-5p expression was decreased in Rb cells after etoposide treatment. When the miR-513a-5p inhibitor was added, B7-H1 expression was increased with the concentration of the miR-513a-5p inhibitor (P<0.05). Moreover, B7-H1 expression was decreased gradually with the concentration of the miR-513a-5p mimics increased (P<0.01). Additionally, the miR-513a-5p mimics were found to inhibit the luciferase activity. It was concluded that etoposide can promote B7-H1 expression in Rb cells, which may be associated with chemoresistance. The promoting effect of etoposide on B7-H1 expression can be reversed by miR-513a-5p mimics. MiR-513a-5p inhibits the mRNA and protein expression of B7-H1 via binding to the 3'-UTR of B7-H1 mRNA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886978     DOI: 10.1007/s11596-012-1004-8

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  14 in total

Review 1.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

3.  Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.

Authors:  Yoshihiko Usui; Youko Okunuki; Takaaki Hattori; Masaru Takeuchi; Takeshi Kezuka; Hiroshi Goto; Masahiko Usui
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 5.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

6.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

7.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

Review 8.  B7-H1 pathway and its role in the evasion of tumor immunity.

Authors:  Haidong Dong; Lieping Chen
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

9.  MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes.

Authors:  Ai-Yu Gong; Rui Zhou; Guoku Hu; Xiaoqing Li; Patrick L Splinter; Steven P O'Hara; Nicholas F LaRusso; Garrett A Soukup; Haidong Dong; Xian-Ming Chen
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

Review 10.  MicroRNAs in cell proliferation, cell death, and tumorigenesis.

Authors:  H-W Hwang; J T Mendell
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more
  11 in total

Review 1.  Epigenetic regulation of human retinoblastoma.

Authors:  Usha Singh; Manzoor Ahmad Malik; Sandeep Goswami; Swati Shukla; Jasbir Kaur
Journal:  Tumour Biol       Date:  2016-09-17

2.  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.

Authors:  George Pentheroudakis; Yael Spector; Dimitrios Krikelis; Vassiliki Kotoula; Eti Meiri; Vassiliki Malamou-Mitsi; George Fountzilas; Mats Sanden; Nicholas Pavlidis; Hila Benjamin; Ranit Aharonov
Journal:  Clin Exp Metastasis       Date:  2012-11-04       Impact factor: 5.150

3.  Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma.

Authors:  Takuma Higuchi; Hiroshi Todaka; Yasunori Sugiyama; Masafumi Ono; Nobuyuki Tamaki; Etsuro Hatano; Yuka Takezaki; Kazuhiro Hanazaki; Takeshi Miwa; Sylvia Lai; Keiko Morisawa; Masayuki Tsuda; Taketoshi Taniguchi; Shuji Sakamoto
Journal:  J Biol Chem       Date:  2016-08-12       Impact factor: 5.157

Review 4.  The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy.

Authors:  Jessica Ann Chacon; Keith Schutsky; Daniel J Powell
Journal:  Vaccines (Basel)       Date:  2016-11-14

5.  miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease.

Authors:  Nan Dai; Yi Qing; Yanping Cun; Zhaoyang Zhong; Chongyi Li; Shiheng Zhang; Jinlu Shan; Xiao Yang; Xiaoyan Dai; Yi Cheng; He Xiao; Chengxiong Xu; Mengxia Li; Dong Wang
Journal:  Oncotarget       Date:  2016-08-02

6.  Key questions about the checkpoint blockade-are microRNAs an answer?

Authors:  Mihnea Dragomir; Baoqing Chen; Xiao Fu; George A Calin
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

Review 7.  Recent Findings in the Regulation of Programmed Death Ligand 1 Expression.

Authors:  Xiangfeng Shen; Lihong Zhang; Jicheng Li; Yulin Li; Yishu Wang; Zhi-Xiang Xu
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

Review 8.  MicroRNAs: immune modulators in cancer immunotherapy.

Authors:  Yun Xing; Zhiqiang Wang; Zhou Lu; Jie Xia; Zhangjuan Xie; Mengxia Jiao; Ronghua Liu; Yiwei Chu
Journal:  Immunother Adv       Date:  2021-05-13

9.  miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer.

Authors:  Lianzhou Yang; Yuchen Cai; Dongsheng Zhang; Jian Sun; Chenyu Xu; Wenli Zhao; Wenqi Jiang; Chunhua Pan
Journal:  J Breast Cancer       Date:  2018-12-26       Impact factor: 3.588

10.  The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.

Authors:  Paolo A Ascierto; Carlo Bifulco; Jerome Galon; Claus Garbe; Samir N Khleif; Jennifer McQuade; Kunle Odunsi; Hideho Okada; Chrystal M Paulos; Sergio A Quezada; Hussein A Tawbi; John Timmerman; Giorgio Trinchieri; Lisa H Butterfield; Igor Puzanov
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.